Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Arthritis, Psoriatic, Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00245960
What this trial is testing

Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Wyeth is now a wholly owned subsidiary of Pfizer 752
Testing effectiveness (Phase 2)Study completedNCT00678782
What this trial is testing

Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint Synovitis

Who this might be right for
Persistent Knee Joint Synovitis
University of Padova 31
Not applicableLooking for participantsNCT06764693
What this trial is testing

An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
AbbVie 1,200
Large-scale testing (Phase 3)Study completedNCT04936308
What this trial is testing

Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 453
Large-scale testing (Phase 3)Study completedNCT03796858
What this trial is testing

Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy

Who this might be right for
Arthritis, Psoriatic
Janssen Pharmaceutica N.V., Belgium 285
Large-scale testing (Phase 3)Study completedNCT02584855
What this trial is testing

A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Eli Lilly and Company 394
Not applicableLooking for participantsNCT06586281
What this trial is testing

Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy

Who this might be right for
Psoriatic Arthritis
University of California, San Diego 20
Large-scale testing (Phase 3)Study completedNCT01892436
What this trial is testing

Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 460
Not applicableStudy completedNCT00293722
What this trial is testing

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists

Who this might be right for
Arthritis, PsoriaticPsoriasisSkin Diseases, Papulosquamous
Pfizer 1,308
Not applicableStudy completedNCT00902005
What this trial is testing

Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis+2 more
Revmatismesykehuset AS 145
Testing effectiveness (Phase 2)Study completedNCT00267956
What this trial is testing

An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Centocor, Inc. 146
Post-approval studies (Phase 4)Looking for participantsNCT07111494
What this trial is testing

Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial

Who this might be right for
Psoriatic Arthritis (PsA)
Medical College of Wisconsin 22
Large-scale testing (Phase 3)Study completedNCT02181673
What this trial is testing

Golimumab in Participants With Active Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 480
Large-scale testing (Phase 3)Study completedNCT01172938
What this trial is testing

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Amgen 504
Not applicableStudy completedNCT00580632
What this trial is testing

Study Evaluating Workload, Clinical and Therapeutic Management of Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Wyeth is now a wholly owned subsidiary of Pfizer 300
Not applicableStudy completedNCT02232321
What this trial is testing

Vascular Effects of Achieving Minimal Disease Activity in Psoriatic Arthritis - a 2 Year Prospective Cohort Study

Who this might be right for
Psoriatic ArthritisAtherosclerosisArterial Stiffness
Chinese University of Hong Kong 113
Large-scale testing (Phase 3)Not Yet RecruitingNCT07791199
What this trial is testing

Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers

Who this might be right for
Systemic Lupus ErythematosusSjögren's DiseasePsoriasis+1 more
Bristol-Myers Squibb 2,300
Not applicableActive Not RecruitingNCT05621369
What this trial is testing

Psorcast Mobile Study

Who this might be right for
Psoriatic ArthritisPsoriasisPsoriatic Conditions+6 more
Sage Bionetworks 1,000
Not applicableStudy completedNCT03455166
What this trial is testing

Identification of New Prognostic Markers in Psoriatic Arthritis

Who this might be right for
PsoriasisPsoriatic Arthritis
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 100
Post-approval studies (Phase 4)Study completedNCT00127842
What this trial is testing

REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)

Who this might be right for
Psoriatic Arthritis
Amgen 110
Next Page